EHA Unplugged

EHA Unplugged has been a member of Linktree for 3 years and joined in January 2023. The social media accounts linked to from EHA Unplugged are: • Spotify • YouTube • Email • Apple Podcasts Besides social media accounts, ehaunplugged has populated their site with: • How Experts Treat Multiple Myeloma - EHA Unplugged | Podcast on Spotify • Where Are We Now With Immunotherapy in Multiple Myeloma? - EHA Unplugged | Podcast on Spotify • Menin Inhibitors to Treat Acute Myeloid Leukemia (AML) - EHA Unplugged | Podcast on Spotify • How Experts Treat HIV-associated Lymphomas - EHA Unplugged | Podcast on Spotify • Spotify • Hematology Portraits: Associate Prof Meritxell Alberich Jordà - EHA Unplugged | Podcast on Spotify • How Experts Treat Large B-cell Lymphoma (LBCL) - EHA Unplugged | Podcast on Spotify • How Experts Treat Large B-cell... - EHA Unplugged - Apple Podcasts • Connecting Hematology Research and Real Life: Peter Kapitein - EHA Unplugged | Podcast on Spotify • How Experts Treat Peripheral T- and NK-cell Lymphomas - EHA Unplugged | Podcast on Spotify • Hematology Portraits: Prof Konstanze Döhner - EHA Unplugged | Podcast on Spotify • How Blood Cells Age: From Stem Cells to Clones (with Dr Michael Milsom) - EHA Unplugged | Podcast on Spotify • How Experts Treat Mantle Cell Lymphoma (with Prof Mats Jerkeman) - EHA Unplugged | Podcast on Spotify • EHA Junior Research Grant: Dr Ana Río-Machín’s Journey in AML Research and Collaborative Science - EHA Unplugged | Podcast on Spotify • Hematologists’ Role in the Management of Gaucher Disease (Prof Argiris Symeonidis and Prof Sam Salek) - EHA Unplugged | Podcast on Spotify • Navigating the Toughest Challenges in Hematology Nursing: Insights from HNHCP Leaders - EHA Unplugged | Podcast on Spotify • A Multiple Myeloma and MRD Pioneer: EHA 2025 Lifetime Achievement Award (Prof Jesús San-Miguel) • Young Hematologists in the Spotlight: EHA2025 Young EHA Award (Dr Mandy Lauw) - EHA Unplugged | Podcast on Spotify • Supporting Hematology Innovation: Outcomes of an EHA Junior Research Grant (with Dr Ferran Nadeu Prat) - EHA Unplugged | Podcast on Spotify • Ethical Considerations in Gene Therapy for Sickle Cell Disease and Thalassemia (with Prof Mariane de Montalembert) • Point-of-care Tests for Neonatal Screening of Sickle Cell Disease (with Prof Béatrice Gulbis) • What the EHA Burnout Survey Reveals for Hematologists (with Dr. Côme Bommier) - EHA Unplugged | Podcast on Spotify • EHA2025 Diversity, Equity, and Inclusion Award: Prof Anna Schuh - EHA Unplugged | Podcast on Spotify • A Successful Mentor’s Mindset: EHA2025 Education & Mentoring Award (Jan Cools) - EHA Unplugged | Podcast on Spotify • EHA Clinical Excellence Award 2025: Prof Khaled Musallam - EHA Unplugged | Podcast on Spotify • Setting the Standard for Quality Care in Hematologic Malignancies (with Prof John Gribben) - EHA Unplugged | Podcast on Spotify • Hematology Portraits: Prof Kirsten Grønbæk - EHA Unplugged | Podcast on Spotify • Hematology Portraits: Prof Maria Domenica Cappellini - EHA Unplugged | Podcast on Spotify • Gene Therapy Advances in SCD and B-Thalassemia (with Dr Stefano Rivella) • AML Management in the Old and Unfit (with Prof Hartmut Döhner) - EHA Unplugged | Podcast on Spotify • Managing Young Fit AML patients with Prof Konstanze Döhner • GoCART Coalition • Empowering Healthcare through Patient Advocacy (with Jan Geissler) • Off-the-shelf CAR T-cells from iPSCs (with Prof Maria Themeli) • AIDPATH – AI automated CAR T-cell manufacturing (with Dr Carmen Sanges) • Hematology Portraits: prof. Elizabeth Macintyre • Is low-risk MDS really low risk? (with Prof Uwe Platzbecker) • MRD Monitoring in MDS Patients (with Prof Arjan van de Loosdrecht) • Hematology Portraits: prof. Martin Dreyling • MDS Pathophysiology and the Role of Immune Dysfunction (with Dr Shahram Kordasti) • Revolutionizing Patient Registries to Promote Research and Improve Health Outcomes • Targeting the Immune System in MDS (featuring Prof Dominik Wolf) • Accelerating Clinical Trials with AI (with Dr Jan Moritz Middeke) • The Current Diagnostic Approach to MDS (with Dr Onima Chowdhury) • Hematology Portraits: Prof Brian Huntly • Mental Health in CLL • Patient Perspectives on Gene Therapy for Sickle Cell Disease and B-Thalassemia • Hematology Portaits: Kostas Stamatopoulos • Management of High-risk MDS: Seeking Clarity for Classification and Treatment • Hematopoietic Stem Cells in Health, Aging and Malignancy: Focus on Metabolism (EHA2024) • Innovative Trial Design (EHA2024) • Hereditary Hematological Malignancies (HHMs): A New Era of Discovery in MDS and AML (EHA2024) • Hairy Cell Leukemia (HCL): Treatment of Relapsed Disease (EHA2024) • Iron Metabolism in Myelodysplastic Syndrome (MDS) • First-line Treatment of Primary Central Nervous System Lymphoma (PCNSL) (EHA2024) • Optimizing Global Care for Women with von Willebrand Disease (VWD) (EHA2024) • Videos now on Spotify & YouTube • Iron and Infections: Back to the Future (EHA2024) • Long-term Outcomes in the Chemo-free era for Acute Promyelocytic Leukemia (EHA2024) • Thrombotic thrombocytopenic purpura (TTP): Is plasmapheresis history? • The Role of Artificial Intelligence in Hematology (featuring Dr Gregor Hormann) • From MDS to AML: Genetics of Progression (with Prof Lars Bullinger) • Screening for Sickle Cell Disease (with Prof David Rees) • Circulating Tumor DNA • All Good Things Must Come to an End: How and When to End a Clinical Trial (Clinical Trial) • Iron Deficiency: Perioperative • Documentation and authorization: Safeguarding the Credibility of Clinical Trials (Clinical Trial) • Engraftment and Chimerism following HSCT • The History of HSCT • The Environmental Impact on Hematology Practice (with Dr Stephen Hibbs) • Hematology Portraits: prof. Antonio Almeida • Health Technology Assessment (HTA) • Treating CML in Developing Countries • Ethical Issues Associated with Treating Hematological Malignancies in Older Adults (Aging Patient: Dispelling Myths) • Infections in HSCT • Synthetic Patients: The Future of Clinical Trials? • EHA Unplugged • CAR T Podcast Playlist • Less is More - Transfusion • Sponsor: A Role to Take Seriously (Clinical Trial) • Graft-versus-Host Disease in HSCT • Innovative tools for Disease Monitoring in Multiple Myeloma • Hematology Portraits: Prof Ivo Touw • Chronic Myeloid Leukemia (Naomi) • Hematological Changes in Older Adults (Aging Patient: Dispelling Myths) • Preventing Venous Thromboembolism (VTE) in Pregnant Women • Papers Unplugged: Is CAR-T Economically Sustainable? • Patient Support: Relate and Create (Clinical Trial) • Listen on EHA Campus • Microlearning from EHA • Gene Therapy for Hemophilia • Building prognostic models using big data with Prof Kimmo Porkka • Treatment of Hematological Malignancies in Older Adults (Aging Patient: Dispelling Myths) • AI-driven Morphology in Hematology • The Paper Trail (CRO) (Clinical Trial) • Regulatory Landscape for CAR T-cell Therapy • Patient Assessment In Older Adults (Aging Patient: Dispelling Myths) • Point-of-care CAR T-cell Manufacturing • Multiple Myeloma in Underserved Populations (Episode 3) • Processes in CAR T-cell Therapy • What matters in a trial design? (Clinical Trial) • CAR T-cell Therapy for Children with ALL • Aging and Clonal Diseases (Aging Patient: Dispelling Myths) • CAR T-cell Therapy in AML: State of the Art • Iron Deficiency: Women • Ethical Considerations in CAR T-cell Therapy • Iron Deficiency: Chronic Kidney Disease • CAR T-cell Therapy - A Patient's Perspective • Iron Deficiency: Heart Failure • Developments in CAR T-cell Therapy • HSCT in Multiple Myeloma • Precision Medicine in Myelodysplastic Syndromes (MDS) • Multiple Myeloma in Underserved Populations (Episode 2) • Diversity, Equity, and Inclusion in Hematology • Chronic Lymphocytic Leukemia (CLL) • Trends in CAR T-cell Therapy • Chronic Myeloid Leukemia (CML) • Precision Medicine in Chronic Lymphocytic Leukemia (CLL) • SCD: What Physicians Can Learn From Patients And Carriers (Episode 3) • Precision Medicine in Rare Hematological Diseases: Pyruvate Kinase Activators • Multiple Myeloma in Underserved Populations (Episode 1) • Precision Medicine in Follicular Lymphoma • SCD: What Physicians Can Learn From Patients And Carriers (Episode 2) • Precision Medicine in Multiple Myeloma • BCR-ABL1-like ALL • Precision Medicine in Myeloproliferative Neoplasms • ALL Hope For The Future • Precision Medicine and Clonal Hematopoiesis • Iron Homeostasis in Host Defense and Inflammation • Precision Medicine: Hepcidin Mimetics for Polycythemia Vera Treatment • SCD: What Physicians Can Learn From Patients And Carriers (Episode 1) • Precision Medicine in Inherited Bone Marrow Failure Syndromes • Impact of Social Stigma on Coping with SCD • The Whats in Scientific Publishing • Interventions in Adolescent SCD • The New Classification of Hemochromatosis: Why and How • Sickle Cell Disease in Pregnancy • Diversity, equity, and inclusion: Why this is important? • HSCT in Paroxysmal Nocturnal Hemoglobinuria • Unraveling Autoimmune Neutropenia: From Childhood to Adulthood • HSCT in Severe Aplastic Anemia • Navigating the World of Hematology Research: from Mentorship to Work-Life Balance • Myelodysplastic Syndrome (MDS) with Prof Kirsten Grønbæk • Immune cell therapies and targeted therapies in AML • Patient Communication and Self Care • Myeloma - Prof Jorge Sierra • Lymphoma - Dr Umut Yilmaz • How to Get Started in Hematology Research - Dr Anastasia Conti, Assoc Prof Maria Paola Martelli and Dr Simona Valletta • Pediatric Hematology - Dr Mirjam Belderbos • Iron metabolism: physiology and pathology • Pathogenesis and Management of Acute Chest Syndrome (ACS) in SCD • Latest Innovations and Future Perspectives in CAR-T Therapy • EHA Unplugged: MDS classification and risk assessment • Current CAR-T Treatment for Lymphomas Focusing on DLBCL • New Treatment of Iron Metabolism Defects: A Focus on Anemia of Inflammation • Clinical Management of CAR-T Therapy in Myeloma • Challenges in receiving CAR-T treatment: Patient's perspective • Ph+ acute lymphoblastic lymphoma and the immune system in hematological neoplasms. • CAR-T Treatment in Myeloma: State of the Art • Reasons for Failure and Relapse and Mechanisms of Resistance in CAR-T • Economic Aspects of CAR-T: Challenges and Solutions • Update on CAR-T Therapies in Acute and Chronic Leukemias • Spotlight Talks: How I Treat Absolute Iron Deficiency in Inflammatory Disorders • Overview of the Current CAR-T Landscape • Papers Unplugged: Precision Medicine and Myeloid Neoplasms • Debate: Gene Addition or Gene Editing for Hemoglobinopathies? • What's in Store for Lymphoid Malignancies? • Spotlight Talks: Postpartum Hemorrhage (PPH) • Papers Unplugged: The Perspectives of Doctors and Patients in the Treatment of CLL • Papers Unplugged: Precision Medicine in AML • Debate: Should Low Risk PV-MF Patients be Treated? • Spotlight Talks: New Agents for the Treatment of Thalassemia • Papers Unplugged: What's New in the Treatment of CLL? • Spotlight Talks: Updates on the Classification of Hematolymphoid Neoplasms—Myelodysplastic Syndromes • Papers Unplugged: TIF Guidelines for the Management of Patients with Transfusion-Dependent Thalassemia (TDT) • Spotlight Talks: Updates on the Classification of Hematolymphoid Neoplasms—Lymphoid Diseases • Papers Unplugged: EHA and War in Ukraine • Papers Unplugged: What Ever Happened to Plan S? • Papers Unplugged: CHIP and Associated Risk in Elderly Patients • Papers Unplugged: Precision Medicine and Hemoglobinopathies • Naive CLL • Thrombosis - Bleeding in Cancer • The Microbiome in HCT • Diagnosing Erythrocytosis • Clinical Trials of the Future (Clinical Trial) • Cutaneous T Cell Lymphoma (CTCL) Episode 2: Treatment • Cutaneous T Cell Lymphoma (CTCL) Episode 1: Presentation and Diagnosis